2CN0 image
Deposition Date 2006-05-17
Release Date 2006-11-06
Last Version Date 2023-12-13
Entry Detail
PDB ID:
2CN0
Title:
Complex of Recombinant Human Thrombin with a Designed Inhibitor
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
HIRUDO MEDICINALIS (Taxon ID: 6421)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.30 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:PROTHROMBIN PRECURSOR
Gene (Uniprot):F2
Chain IDs:A (auth: H)
Chain Length:257
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:HIRUDIN IIA
Chain IDs:B (auth: I)
Chain Length:11
Number of Molecules:1
Biological Source:HIRUDO MEDICINALIS
Polymer Type:polypeptide(L)
Molecule:PROTHROMBIN PRECURSOR
Gene (Uniprot):F2
Chain IDs:C (auth: L)
Chain Length:28
Number of Molecules:1
Biological Source:HOMO SAPIENS
Peptide-like Molecules
PRD_000481
Primary Citation
Mapping the Fluorophilicity of a Hydrophobic Pocket: Synthesis and Biological Evaluation of Tricyclic Thrombin Inhibitors Directing Fluorinated Alkyl Groups Into the P Pocket
Chemmedchem 1 1205 ? (2006)
PMID: 17001711 DOI: 10.1002/CMDC.200600124

Abstact

In the completion of our fluorine scan of tricyclic inhibitors to map the fluorophilicity/fluorophobicity of the thrombin active site, a series of 11 new ligands featuring alkyl, alkenyl, and fluoroalkyl groups was prepared to explore fluorine effects on binding into the hydrophobic proximal (P) pocket, lined by Tyr 60A and Trp 60D, His 57, and Leu 99. The synthesis of the tricyclic scaffolds was based on the 1,3-dipolar cycloaddition of azomethine ylides, derived from L-proline and 4-bromobenzaldehyde, with N-(4-fluorobenzyl)maleimide. Introduction of alkyl, alkenyl, and partially fluorinated alkyl residues was achieved upon substitution of a sulfonyl group by mixed Mg/Zn organometallics followed by oxidation/deoxyfluorination, as well as oxidation/reduction/deoxyfluorination sequences. In contrast, the incorporation of perfluoroalkyl groups required a stereoselective nucleophilic addition reaction at the "upper" carbonyl group of the tricycles, thereby yielding scaffolds with an additional OH, F, or OMe group, respectively. All newly prepared inhibitors showed potent biological activity, with inhibitory constants (K(i) values) in the range of 0.008-0.163 microM. The X-ray crystal structure of a protein-ligand complex revealed the exact positioning of a difluoromethyl substituent in the tight P pocket. Fluorophilic characteristics are attributed to this hydrophobic pocket, although the potency of the inhibitors was found to be modulated by steric rather than electronic factors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures